Oshkosh Corporation Has Become Irresistible After Its Plunge Lower

Oshkosh Corporation was upgraded to “Strong Buy,” with the bullish view citing undervaluation and revenue growth despite recent share underperformance and mixed bottom-line results. Management forecasts adjusted EPS of $18–$22 by 2028; at current multiples, achieving that range would imply annualized upside of more than 30%.

Analysis

The setup is a credibility-and-multiple trade, not simply an EPS-growth trade. If investors gain confidence that management can deliver the 2028 earnings range through a full cycle, OSK could benefit from both earnings growth and a narrower valuation discount. But the cited upside calculation is highly sensitive to the assumed exit multiple and starting price; the EPS target alone does not establish that return. Oshkosh’s exposure to equipment and vehicle demand also leaves the path vulnerable to order deferrals, weaker utilization, or a downturn that depresses earnings and the multiple at the same time. Over the next 1–3 months, guidance detail, order trends, and evidence that revenue growth is translating into earnings matter more than the headline upgrade. Over 6–18 months, delivery against the earnings trajectory is the key re-rating test. The contrarian risk is that a low valuation may reflect cycle and execution uncertainty rather than a mispricing. The supplied data do not include current valuation, consensus estimates, or segment-level order and margin trends, so the analyst’s upside case cannot be independently underwritten here.

Key Decisions for Investors

• Treat the upgrade as a thesis to verify, not a near-term catalyst by itself. Before adding, check OSK’s current valuation against its own cycle history and peers, consensus earnings revisions, and the assumptions behind the 2028 adjusted EPS range.
• For a 1–3 month position, consider only a staged long after the next results or guidance update confirms that order conversion and earnings progression support the target. Without those checks, there may be no immediate trade; avoid sizing from the stated 30%+ upside figure alone.
• Falsify the bull case if management lowers the 2028 range, near-term earnings estimates are revised down despite revenue growth, or order/backlog indicators weaken. A broad industrial-demand slowdown would also undermine the thesis by pressuring both earnings expectations and valuation.
• Watch for a 6–18 month re-rating only if OSK converts growth into sustained earnings delivery. If results meet the earnings path but the valuation remains discounted, investigate whether cycle exposure or business mix is the persistent market concern before extending the position.